edistride
astrazeneca ab - monohydrat propanoilu dapagliflozyny - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - leki stosowane w cukrzycy - type 2 diabetes mellitusedistride is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. oprócz innych leków do leczenia cukrzycy typu 2 . for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 i 5. heart failureedistride is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseedistride is indicated in adults for the treatment of chronic kidney disease.
forxiga
astrazeneca ab - monohydrat propanoilu dapagliflozyny - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - leki stosowane w cukrzycy - type 2 diabetes mellitusforxiga is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. oprócz innych leków do leczenia cukrzycy typu 2 . for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 i 5. heart failureforxiga is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseforxiga is indicated in adults for the treatment of chronic kidney disease.
hydrocortisone momaja 100 mg proszek i rozpuszczalnik do sporządzania roztworu do wstrzykiwań / do infuzji
panpharma - hydrocortisonum - proszek i rozpuszczalnik do sporządzania roztworu do wstrzykiwań / do infuzji - 100 mg
dapagliflozin viatris
viatris limited - dapagliflozin - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - leki stosowane w cukrzycy - type 2 diabetes mellitusdapagliflozin viatris is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance. - in addition to other medicinal products for the treatment of type 2 diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 i 5. heart failuredapagliflozin viatris is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction. chronic kidney diseasedapagliflozin viatris is indicated in adults for the treatment of chronic kidney disease.
pioglitazone bioton 15 mg tabletki
bioton s.a. - pioglitazonum - tabletki - 15 mg
pioglitazone bioton 30 mg tabletki
bioton s.a. - pioglitazonum - tabletki - 30 mg
pioglitazone bioton 45 mg tabletki
bioton s.a. - pioglitazonum - tabletki - 45 mg
glucosum teva 400 mg/ml roztwór do wstrzykiwań
teva pharmaceuticals polska sp. z o.o. - glucosum - roztwór do wstrzykiwań - 400 mg/ml
glucosum teva 200 mg/ml roztwór do wstrzykiwań
teva pharmaceuticals polska sp. z o.o. - glucosum - roztwór do wstrzykiwań - 200 mg/ml
adeksa 50 mg tabletki
polfarmex s.a. - acarbosum - tabletki - 50 mg